The majority of patients with acute myeloid leukemia (AML) reach complete remission after high-dose chemotherapy. Still, half of these patients experience a relapse due to presence of minimal residual disease (MRD). Here we discuss the poor prognostic role of class II-associated invariant chain peptide (CLIP) expression on residual leukemic cells.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353169 | PMC |
| http://dx.doi.org/10.4161/21624011.2014.941737 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Immune Aging in Rheumatoid Arthritis.
Arthritis Rheumatol
January 2025
Department of Medicine, Mayo Clinic Alix School of Medicine, Rochester, MN, 55905, USA.
Rheumatoid arthritis (RA) is a life-long autoimmune disease caused by the confluence of genetic and environmental variables that lead to loss of self-tolerance and persistent joint inflammation. RA occurs at the highest incidence in individuals >65 years old, implicating the aging process in disease susceptibility. Transformative approaches in molecular immunology and in functional genomics have paved the way for pathway paradigms underlying the replacement of immune homeostasis with auto-destructive immunity in affected patients, including the process of immune aging.
View Article and Find Full Text PDFDefective removal of invariant chain peptides from MHC class II suppresses tumor antigen presentation and promotes tumor growth.
Cell Rep
January 2025
Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address:
Tumor-draining lymph node dendritic cells (DCs) are poor stimulators of tumor antigen-specific CD4 T cells; however, the mechanism behind this defect is unclear. We now show that, in tumor-draining lymph node DCs, a large proportion of major histocompatibility complex class II (MHC-II) molecules retains the class II-associated invariant chain peptide (CLIP) fragment of the invariant chain bound to the MHC-II peptide binding groove due to reduced expression of the peptide editor H2-M and enhanced activity of the CLIP-generating proteinase cathepsin S. The net effect of this is that MHC-II molecules are unable to efficiently bind antigenic peptides.
View Article and Find Full Text PDFDifferences in Cytokine Expression at Baseline and in Response to Mineral Stimulation by Peripheral Blood Mononuclear Cells from Podoconiosis Cases and Healthy Control Individuals.
Trop Med Infect Dis
October 2024
Armauer Hansen Research Institute, Addis Ababa P.O. Box 1005, Ethiopia.
Article Synopsis
- Podoconiosis is a non-infectious tropical lymphoedema affecting around 4 million people, linked to HLA class II and triggered by unknown factors in volcanic red clay soils.
- The study measured immune responses in podoconiosis patients by analyzing cytokine levels and gene expressions after exposure to specific minerals, finding that patients had higher baseline cytokine levels but lower responses to mineral stimulation.
- The findings indicate ongoing immune activation in podoconiosis patients, highlighting the need for further research to understand immune dysfunction and potentially develop early detection methods for this preventable disease.
Structural insights into human MHC-II association with invariant chain.
Proc Natl Acad Sci U S A
May 2024
Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA 94305.
The loading of processed peptides on to major histocompatibility complex II (MHC-II) molecules for recognition by T cells is vital to cell-mediated adaptive immunity. As part of this process, MHC-II associates with the invariant chain (Ii) during biosynthesis in the endoplasmic reticulum to prevent premature peptide loading and to serve as a scaffold for subsequent proteolytic processing into MHC-II-CLIP. Cryo-electron microscopy structures of full-length Human Leukocyte Antigen-DR (HLA-DR) and HLA-DQ complexes associated with Ii, resolved at 3.
View Article and Find Full Text PDFA 10-year-old boy with class II oligodontia treated with buccal fixed appliances and agenesis space closure of the four second premolars: Case report No. 230075 - Titularisation Collège Européen Orthodontie (CEO), European College of Orthodontics.
Int Orthod
June 2024
10, avenue Auguste-Renoir, 78160 Marly-le-Roi, France. Electronic address:
The patient presented in this case report is a 10-year-old boy with hyperdivergent skeletal Class II associated with familial genetic agenesis of the second premolars. The treatment plan chosen was to close the spaces of agenesis using a bimaxillary appliance fixed buccally. The advantages and disadvantages of this treatment option were discussed.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!